|
|
 |
|
UNAUDITED STANDALONE FINANCIAL RESULTS (PROVISIONAL) FOR THE QUARTER
ENDED MARCH 31, 2009. |
| (Rs. In Lacs) |
PARTICULARS |
Quarter Ended 31/3/2009 |
Quarter Ended 31/3/2008 |
Nine Months
Ended 31/3/2009 |
Nine Months
Ended 31/3/2008 |
Year Ended 30/06/2008(Audited) |
| Net Sales / Income from Operations |
10803.46 |
8152.49 |
29332.04 |
21956.08 |
33461.6 |
| Total Income |
10803.46 |
8152.49 |
29332.04 |
21956.08 |
33461.6 |
| Total Expenditure |
|
|
|
|
|
| a) Increase/(Decrease) in Stock in Trade |
(715.02) |
(658.31) |
(2066.72) |
(1676.56) |
(3147.92) |
| b) Consumption of Materials |
8935.16 |
7461.04 |
25677.7 |
19976.23 |
31972.28 |
| c) Purchases of Trading Goods |
1160.18 |
- |
1848.31 |
- |
- |
| d) Employees Cost |
151.76 |
131.92 |
436.07 |
302.76 |
374.27 |
| e) Depreciation |
128.34 |
83.85 |
414.72 |
240.03 |
359.96 |
| f) Other Expenditure |
201.55 |
139.06 |
585.05 |
292.55 |
355.45 |
| Total |
9,861.97 |
7,157.56 |
26,895.13 |
19,135.01 |
29,914.04 |
| Profit from Operations before Exchange Rate Difference, |
|
|
|
|
|
| Other Income, Interest & Exceptional Items ( 1 - 2 ) |
941.49 |
994.93 |
2,436.91 |
2,821.07 |
3,547.56 |
| Other Income |
12.81 |
80.35 |
152.99 |
125.56 |
250.51 |
| Profit from Operations before Interest & Exceptional |
|
|
|
|
|
| Items ( 3 + 4 ) |
954.30 |
1,075.28 |
2,589.90 |
2,946.63 |
3,798.07 |
| Interest |
401.52 |
169.38 |
987.86 |
432.49 |
658.70 |
| Exception Items |
435.09 |
- |
468.46 |
- |
- |
| Profit Before Tax ( 3 - 6 - 7 ) |
117.69 |
905.90 |
1,133.58 |
2,514.14 |
3,139.37 |
| Tax Expenses |
15.00 |
155.30 |
133.00 |
491.00 |
420.57 |
| Net Profit before ordinary activities ( 8 - 9 ) |
102.69 |
750.60 |
1,000.58 |
2,023.14 |
2,718.80 |
| Extra Oridinary Items (Net of Tax) |
- |
- |
- |
- |
- |
| Net Profit after Taxes ( 10 - 11) |
102.69 |
750.60 |
1,000.58 |
2,023.14 |
2,718.80 |
| Paid Up Equity Share Capital ( Face Value Of Rs. 10/- each) |
1,055.69 |
1,018.19 |
1,055.69 |
1,018.19 |
1,055.69 |
| Reserves excluding Revaluation |
- |
- |
- |
- |
- |
| Reserves |
- |
- |
- |
- |
8,862.88 |
| Earning Per Shares |
|
|
|
|
|
| i) before extra ordinary items |
0.97 |
7.37 |
9.48 |
19.87 |
25.75 |
| ii) after extra ordinary items |
0.97 |
5.16 |
9.48 |
17.66 |
25.75 |
| Aggregate of Public Shareholdings |
|
|
|
|
|
| No. of Shares |
4,144,325 |
3,769,325 |
4,144,325 |
3,769,325 |
4,144,325 |
| Percentage of Shareholdings |
39.26% |
37.02% |
39.26% |
37.02% |
39.26% |
| Promoters & promoter group Shareholding |
|
|
|
|
|
| a) Pledged / Encumbered |
|
|
|
|
|
| - Number of Shares |
- |
- |
- |
- |
- |
| - Percentage of Shares(as a % of the total shareholding of promoter & promoter group) |
- |
- |
- |
- |
- |
| b) Non-encumbered |
|
|
|
|
|
| - Number of Shares |
6,412,575 |
- |
6,412,575 |
- |
- |
| - Percentage of Shares(as a % of the total shareholding of promoter & promoter group) |
100% |
- |
100% |
- |
- |
| - Percentage of Shares(as a % of the total share capital of the Company) |
60.74% |
- |
60.74% |
- |
- |
| NOTES :- |
| 1) The above results for the quarter ended March 31, 2009 have been reviewed by the Audit Committee and were taken on record by |
| the Board of Directors in its meeting held on April 30, 2009. |
| 2) The "Limited Review" required under clause 41 of listing agreement has been done by statutory auditors of the Company. |
| 3) The Company has provided for Foreign Exchange (Loss)/Gains under Exception Items due to exchange differences arising during the |
| period(s) on foreign currency contracts and borrowings including Foreign Currency Convertible Bonds. |
| 4) Previous years figures have been regrouped and recast wherever necessary. |
| 5) Information on investor complaints for the quarter ended March 31, 2009 (in nos.) |
|
| Opening Balance of Complaints |
Received during the Quarter |
Disposed Off during the Quarter |
Closing Balance |
| NIL |
1 |
1 |
NIL |
|
|
|
| |
|
Place : Mumbai.
Date :30.04.2009 |
By Order Of The Board
For SharonBio Medicine Ltd.
Sd/-
M.P.Kala
Director |
|
.
|
|
|
|
|
 |
|
